ColombiaBackground: Maternal immunization with tetanus, diphtheria, and acellular pertussis (Tdap) vaccine confers protection to young infants. We aimed to describe trends in pertussis incidence and associated mortality in children aged <12 months before and after introduction of maternal Tdap immunization...
HispanicinfantTetanus toxoidreduced diphtheria toxoidand acellular pertussis (Tdap) vaccineObjectives: Hispanic infants are at greater risk of pertussis compared with other racial/ethnic groups. Studies have shown that the source of Bordetella pertussis infection for most infants is household members. Using...
in individual countries) is a Tdap5 (i.e. combined tetanus toxoid, reduced diphtheria toxoid, five component acellular pertussis [namely detoxified pertussis toxin, filamentous hemagglutinin, pertactin, and fimbriae types 2 and 3]) vaccine for the prevention of diphtheria, tetanus, and pertussis. ...
unvaccinated/partially vaccinated contacts, was 50 % [95 % confidence interval (CI): 19–69 %, p < 0.01] when household contacts were vaccinated using DTaP, Tdap, hexavalent or heptavalent vaccines, and it was 51.3 % (95 % CI: 21–70 %, p < 0.01) when they were vaccinated using ...
▴ Tdap had a similar reactogenicity profile, including solicited local reactions and general symptoms, to that of the approved Td vaccine in the pivotal US study. In particular, Tdap was similar (non-inferior) to Td with respect to the primary safety endpoint, namely the incidence of grade ...
Tdapmaternal immunizationTdap vaccine administered to a mother during the third trimester of pregnancy is 77.7% effective at preventing pertussis in infants <2 months of age.Tami HSkoffAmy EBlainJamesWattKarenScherzingerMelissaMcMahonShelley MZanskyKathyKudishPaul RCieslakMelissaLewisNong...
CDC. Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months-Advisory Committee on Immunization Practices (ACI...
A vaccine for the prevention of infections with . The adjuvant can be aluminum hydroxide and other immunogens such as tetanus toxoid, diphtheria toxoid, or combinations thereof. The Tdap vaccine exhibits cross activity.HOZBOR, DANIELABARTEL, ERIKA...
A vaccine for the prevention of infections with . The adjuvant can be aluminum hydroxide and other immunogens such as tetanus toxoid, diphtheria toxoid, or combinations thereof. The Tdap vaccine exhibits cross activity.DANIELA HOZBORDANIELA BOTTERO...
Background: This study evaluated immunogenicity and safety of the adjuvanted recombinant zoster vaccine (RZV) and the reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine (Tdap) when co-administered in adults aged >= 50 years.Strezova, AnaLal, HimalEnweonye, IgwebuikeCampora, ...